Title:
5 as IGF-1 R/IR inhibitor, and 8-dihydro6H-pyrazolo [3 and 4-H] quinazoline
Document Type and Number:
Japanese Patent JP6128133
Kind Code:
B2
Abstract:
The present invention encompasses compounds of general formula (I) wherein the groups R1 to R6, A, B, C, n, p, q and r are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.
Inventors:
Troy Mathias
Application Number:
JP2014552655A
Publication Date:
May 17, 2017
Filing Date:
January 22, 2013
Export Citation:
Assignee:
Boehringer Ingelheim International GmbH
International Classes:
C07D487/04; A61K31/519; A61K31/5377; A61P29/00; A61P31/04; A61P35/00; A61P37/06
Domestic Patent References:
| JP2007502851A | ||||
| JP2009536959A | ||||
| JP2007509848A | ||||
| JP2013532652A |
Attorney, Agent or Firm:
Koichi Tsujii
Sadao Kumakura
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Kobayashi Machiko
Sadao Kumakura
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Kobayashi Machiko